Epstein Secrets

mal appeal for covered action 2015-016/ Knight Capital TCR & Appendix Irrefutable proof of SEC facilitated fraud. My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited

o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) EFTA00070379 Rule 424b3 Filing (sec gov) The SEC revoked the St

mal appeal for covered action 2015-016/ Knight Capital TCR & Appendix Irrefutable proof of SEC facilitated fraud. My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited

em Cell Therapy until 2008 EFTA00093879 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciilOksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec gov) The SEC revoked the Stem Cell Therapy

mal appeal for covered action 2015-016/ Knight Capital TCR & Appendix Irrefutable proof of SEC facilitated fraud. My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited

em Cell Therapy until 2008 EFTA00093715 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciilOksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) Rule 424b3 Filing (sec.gov) The SEC revoked the Stem Cell Therapy

mal appeal for covered action 2015-016/ Knight Capital TCR & Appendix Irrefutable proof of SEC facilitated fraud. My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited

o was CEO of Stem Cell Therapy until 2008 https://www.sec.gov/Archives/edgar/data/1360479/000136086508000043/sciil0ksbmarch312008.txt In 2009/2010, Stem Cell Therapy did a "financing" with Prolific Bag Man Terren Peizer: Socius Form S-1 (sec.gov) EFTA00070052 Rule 424b3 Filing (sec.gov) The SEC revoked the St